Thailand surrogacy law: permitted, prohibited and unresolved models
The short answer: restricted, approval-based and non-commercial
Thailand does not operate an unrestricted surrogacy market. The principal statute is the Protection of a Child Born by Medically Assisted Reproductive Technology Act, B.E. 2558 (2015), referred to here as the 2015 ART Act. It creates a narrow route for a qualifying married couple, subject to medical and procedural conditions and advance approval by the statutory committee. It is not a general permission for anyone to arrange a pregnancy through a clinic.
Three distinctions matter immediately. First, a non-commercial arrangement may be possible only if every statutory condition and applicable implementing rule is met. Second, commercial surrogacy is prohibited; the Act also separately restricts paid intermediaries and surrogacy advertising, including advertising that is not for profit. Third, a clinic’s willingness to offer treatment, an agency package, a private contract or a proposed amendment is not legal authorization. A contract cannot cure an eligibility or approval defect.
“Altruistic” does not mean unregulated or free of all expenses. The law permits prescribed health and care expenses under implementing rules, but it does not create a general right to pay a surrogate a fee or to pay an agent for matching. Treatment authorization, legal parentage, birth registration, citizenship, travel documents and recognition in another country are separate questions.
Which law controls, and what changed in 2026?
The 2015 ART Act was published in the Royal Thai Government Gazette on 1 May 2015 and provides that it enters into force after 90 days. The English version linked below is an unofficial translation and expressly warns that the formally adopted Thai text is the only text with legal force.
A third-party Thai-language transcription attributed to an official law source was accessible and labels its data as of 11 October 2026, but it warns that later amendments may not be reflected. It is not a substitute for the Royal Gazette or an official current-status check.
The Thai government announced on 19 July 2026 that public consultation on a revised surrogacy bill ran from 2 to 31 July 2026. A Thai-law firm page reports that the proposal had not yet reached the Cabinet and that no amendment had been published in the Royal Gazette, but its date labels conflict: it says “Last reviewed: 5 September 2026” while also describing the law as of 18 October 2026. This is not an official status certificate, and we have not independently confirmed through a current official legislative register whether the bill advanced after the reported period. The 2015 Act is therefore the last enacted framework identified in the sources, not a certified statement of current law. Before acting, verify the latest Royal Gazette and official legislative status.
Do not assume that the 2024 marriage-equality reform automatically rewrote the separate ART Act. The current ART Act still uses “lawful husband and wife” in its surrogacy provisions, and the 2026 proposal itself contemplated changing that terminology.
Who may apply under the current statutory wording?
Section 21 frames the intended applicants as a lawful husband and wife where the wife is unable to carry a pregnancy. The provision is read as requiring at least one intended spouse to be Thai; if the other spouse is foreign, the marriage must have been registered for at least three years. A couple in which neither spouse is Thai is not eligible under the current reading. Because the controlling text is Thai and administrative interpretation can matter in an individual file, confirm the route in writing with HSS and Thai counsel using both passports and the marriage certificate before paying for treatment.
The statute does not provide an open route for single intended parents or unmarried couples. Its husband-and-wife wording also means a same-sex married couple should not assume eligibility solely because marriage equality is recognized elsewhere in Thai law. That question needs a current statutory and administrative answer; the draft amendment discussed in 2026 is not itself that answer.
The wife’s inability to carry a pregnancy is a statutory eligibility issue, not merely a preference for another person to carry. The clinical indication and the physical, psychological and environmental readiness of the applicants, surrogate and any donor must be assessed under the relevant professional rules. A clinic’s private eligibility policy can be stricter than the law, but it cannot relax a statutory requirement.
Who may act as a surrogate?
Under section 21(2)–(4), the surrogate must not be an ascendant or descendant of either intended parent. The default rule is that she must be a blood relative of one of the intended parents. The Act describes the non-relative route as applying where there are no blood relatives of the intended spouses; do not assume, without confirmation, that this simply means no relative is willing or available. Another woman may be considered only under the rules, procedures and conditions prescribed by the Minister of Public Health with advice from the statutory committee. Confirm the precise threshold in writing with HSS under the current Thai text and implementing notification. This is a regulated exception, not permission to recruit any willing person informally.
The surrogate must previously have given birth to a child. If she has a lawful husband or lives with a man as husband and wife, the Act requires his consent. The government service guide for the approval process also states that the surrogate must be no older than 40 on the date of authorization. Because the age limit and the non-relative route depend on implementing instruments and administrative practice, have HSS confirm the currently applicable notification and required proof before selecting a surrogate.
A Thai-law firm’s analysis of the Minister of Public Health criteria dated 25 November 2015 describes further conditions for a non-relative surrogate: age 20–40, the same nationality as one intended spouse, and no more than two surrogacy births for others. These criteria come from a secondary source; confirm them with HSS and against the original notification before treating them as a complete current checklist.
Relationship evidence, prior-birth evidence, partner consent where applicable and the medical and psychosocial assessments should be assembled before a clinic submits the case. Do not rely on a family label, verbal consent or a private agreement to replace the formal criteria.
Which medical and genetic model is allowed?
Section 22 describes two permitted embryo routes: an embryo formed from the intended husband’s sperm and the intended wife’s egg; or an embryo formed using the sperm or egg of one intended spouse together with a donor’s egg or sperm. The section expressly prohibits using the surrogate’s own egg. Traditional surrogacy, where the surrogate supplies the egg, is therefore not an available model under this Act, regardless of what a contract calls it.
Section 23 requires permission from the statutory committee for the particular intended couple before the provider carries out the surrogacy. The service must be provided by a qualified practitioner and a facility meeting the applicable assisted-reproduction standards. The Act and professional rules also require assessments of the applicants, surrogate and donors and regulate embryo handling and genetic testing; sex selection is not permitted under section 18. A clinic’s general licence or marketing statement is not proof that the facility and the individual case satisfy every requirement.
Commercial versus non-commercial surrogacy
Section 24 states that no person may operate surrogacy for commercial benefits. A person who violates it is liable under section 48 to imprisonment for up to 10 years and a fine of up to THB 200,000. These are statutory maximums, not a prediction of the sentence in any individual case. The ban is not limited to an agreement labelled “commercial”; the substance of payments, services and benefits matters.
Section 25 directs the Minister of Public Health, with committee advice, to prescribe rules for the surrogacy arrangement and expenses for maintaining the surrogate’s health during pregnancy, termination of a surrogacy pregnancy, delivery and postnatal care, including care for the child for at least 30 days after birth. The practical line is between expenses expressly permitted by the current rules and a fee, reward, profit share or other commercial benefit. The Act itself does not authorize an unrestricted compensation package.
Before any money changes hands, ask Thai counsel to identify the exact current notification and confirm which receipts, caps, payees and categories of expenditure it allows. Do not invent an “expense allowance” or relabel a fee as reimbursement. A clinic invoice for lawful medical services is not automatically the same thing as a payment to the surrogate or an agent, and each payment should be classified separately.
Paid intermediaries and advertising are separate prohibitions
Section 27 prohibits a person from acting as an intermediary or agent and demanding, accepting or agreeing to accept property or another benefit as remuneration for arranging or suggesting surrogacy. Section 28 separately prohibits advertising or circulating information that a woman is willing to act as a surrogate or that someone is willing to procure a surrogate, whether or not the activity is for commercial benefit. The text therefore reaches beyond a conventional paid agency advertisement.
A matching fee, referral commission, paid introduction or consultancy tied to arranging or recommending a surrogate creates a serious issue under section 27. A public listing or solicitation may create a separate issue under section 28 even if no fee is charged. Section 49 provides for imprisonment up to five years, a fine up to THB 100,000, or both, for violations of sections 27, 28, 33 or 40. The precise application to a particular cross-border service or online communication requires Thai legal advice; do not assume that using a foreign company or private messaging avoids the law.
Approval and the practical sequence
Approval is case-specific and must precede the surrogacy procedure. The official government service guide says the provider submits the application to the Committee for the Protection of a Child Born by Medically Assisted Reproductive Technology through HSS. A Bangkok facility uses the HSS one-stop service; a regional facility may submit through the provincial public-health office. The authority checks completeness, reviews the case through its subcommittee and committee process, and issues a written decision.
The published service guide lists supporting material such as identity and household-registration records, birth and marriage certificates, facility operating and business licences, evidence that the facility meets assisted-reproduction standards, the responsible practitioner’s qualifications and appointment, medical records explaining the indication, readiness assessments, donor assessments where relevant, and consent and explanatory forms for the intended couple and surrogate. This is a working checklist, not a guarantee that every file needs only those documents; current forms and implementing notifications control.
The guide’s summary displays an estimate of “2 months”, but its detailed conditions state that the committee should complete review within 60 working days after receiving a complete application and supporting documents. If review is not completed, the period may be extended by up to 30 working days at a time, no more than twice. Because the summary and detailed conditions use different measures, confirm the current calculation and any extension with HSS before relying on a schedule. A request to correct incomplete documents can also affect timing. Authorization is case-specific. A change in the practitioner, intended couple, surrogate, sperm or egg may require a new application. Do not begin medication, embryo transfer or other surrogacy treatment on the strength of a preliminary clinic discussion. Obtain written authorization and confirm that the approved participants and reproductive material still match the planned procedure.
- Ask the facility for its current HSS/committee standard certification and the responsible doctor’s qualifications.
- Obtain the current application forms and written document checklist directly from HSS.
- Confirm the applicants’ nationality and marriage route, surrogate relationship, prior birth and any required partner consent.
- Get the applicable rules on reimbursable expenses and intermediary restrictions in writing.
- Do not proceed until the specific committee approval is issued and all approved participants and reproductive materials match the planned treatment.
Parentage, birth registration and refusal of the child
Section 29 provides that a child born under the Act using donor sperm, an egg or an embryo, including through surrogacy, is the legitimate child of the intended lawful husband and wife; donors do not acquire family-law or succession rights and duties with the child merely by donating. Section 33 prohibits the intended husband or wife from refusing to accept a child born through the surrogacy. Section 49 attaches criminal penalties to a violation of section 33.
The Act also addresses the written arrangement and birth notification. Section 31 requires the arrangement to be presented to the doctor or birth attendant as evidence for the birth certificate process. Section 32 generally places the duty to notify the birth on the intended parents, with a surrogate notification route in specified situations, including where the intended parents have died, do not live in Thailand or do not appear after the birth. These provisions do not mean every surrogacy contract automatically determines parentage: the arrangement must fall within the Act and the applicable rules.
For a case involving a foreign parent, a non-relative surrogate or a procedure conducted outside the approved route, obtain a separate opinion on parentage and registration rather than extrapolating from section 29. Birth registration is not the same as a passport, nationality decision or recognition of parentage abroad.
Decision matrix: common scenarios
Use this matrix as an initial screening tool, not as a substitute for a case-specific approval or written Thai legal opinion. “Potentially” means only that the scenario may fit one element of the framework; it does not mean that the procedure is authorized.
| Scenario | Current-law position | Practical consequence |
|---|---|---|
| Both intended parents are foreign nationals | Not eligible under the current reading of section 21(1): at least one intended spouse must be Thai. | Do not pay or start treatment based on the 2026 draft. Obtain written confirmation from HSS/Thai counsel. |
| One intended spouse is Thai and the other is not | The three-year registered-marriage condition in section 21(1) may be relevant, alongside every other requirement. | Verify nationality evidence, marriage registration date and the applicable administrative interpretation. |
| A surrogate is a relative, has previously given birth and has required consent | These facts may meet parts of section 21, but do not replace medical assessment and committee permission. | Collect relationship and birth evidence and apply through an eligible provider before treatment. |
| The intended parents offer a fee or an agency charges for matching | Commercial benefit and paid intermediary activity are prohibited under separate provisions. | Do not relabel compensation as expenses; check each proposed payment against the current notifications. |
| The surrogate would use her own egg | Section 22 prohibits use of the surrogate’s egg. | Do not proceed with traditional surrogacy under this Act. |
| A same-sex married couple relies on marriage equality | The current ART Act’s surrogacy provisions still use husband-and-wife language; the 2026 proposal is not itself law. | Obtain a current Thai-law opinion and verify any amendment and commencement date in the Royal Gazette. |
Foreign law and cross-border consequences
A Thai treatment approval does not decide every issue for an international family. The intended parents’ home country may apply its own rules to parentage, citizenship by descent, registration of a foreign birth, passports or emergency travel documents, and recognition of Thai records or judgments. Those rules may distinguish genetic parentage, legal parentage, the person who gave birth and a person named on a birth certificate.
Before treatment, ask the relevant consulate or a lawyer in the country where the child will live which documents and legal steps are required and whether Thai parentage documentation will be accepted. Confirm translation, legalization or apostille requirements with the receiving authority. Separately confirm Thai birth notification and lawful exit requirements. Do not assume that the child receives Thai nationality because of birth in Thailand, or that a Thai birth certificate alone guarantees nationality or entry to another country.
Where intended parents are foreign, eligibility under Thai law must be resolved first. The child’s eventual travel plan cannot cure an unlawful or unapproved procedure, and a proposed amendment cannot be used as if it were already effective.
What to do before signing or paying
Use the following sequence to reduce the risk of an irreversible commitment. Keep written copies of the answers and do not rely solely on an agency’s or clinic’s verbal assurances.
- Freeze the factual record: both intended parents’ nationalities, marital status and registration date, medical indication, proposed surrogate’s relationship and prior-birth evidence, partner status/consent and intended source of each gamete.
- Ask an independent Thai lawyer to map those facts to sections 21–28 of the 2015 ART Act and the current ministerial and committee notifications. Request a written explanation of any non-relative exception or disputed nationality issue.
- Verify the provider’s current certification and practitioner qualifications directly through HSS or the relevant authority; do not rely on a logo, website claim or old certificate.
- Obtain the actual application forms, the complete supporting-document list and confirmation of who submits the case. Make sure all consent forms and the written arrangement are in the required form and language.
- Have each payment itemized and matched to a specific legal basis. Reject success fees, paid matching or recruitment/advertising arrangements unless Thai counsel confirms a lawful basis; a private contract does not legalize a prohibited payment.
- Secure written committee authorization before beginning the surrogacy procedure. Reapply if a material approved participant or reproductive material changes.
- Separately confirm parentage, birth registration, citizenship, travel documents and recognition in the destination country before treatment, not after birth.
Bottom line
The current framework is a tightly controlled, non-commercial model under the 2015 ART Act—not a general surrogacy market. Eligibility, the surrogate’s status, the permitted genetic method, committee approval, facility standards, expenses and restrictions on intermediaries and advertising must all be checked together. Commercial surrogacy, the surrogate’s own egg, paid arranging and surrogate advertising are not made lawful by consent or by calling a payment an expense.
Secondary legal updates describe the 2026 reform as a proposal, but we have not independently confirmed its current status through an official legislative register. The 2015 Act is the last enacted framework identified in the sources, not a certified statement of current law.
Sources and verification notes
- Office of the Council of State — official law index entry for the 2015 ART Act
- Unofficial English translation — Protection of a Child Born by Medically Assisted Reproductive Technology Act B.E. 2558 (2015) — Unofficial English translation; its own notice says the Thai original controls.
- Thai Government Service Guide — application for permission for a surrogacy case — Official government administrative guide for case-specific approval and documents.
- ThaiLawOnline — Surrogacy in Thailand: Laws for Foreign Couples — Secondary Thai-law analysis. The page says “Last reviewed: 5 September 2026” but also describes the law as of 18 October 2026; its date labels conflict, and it is not an official legislative-status certificate.
- Herrera & Partners — Thailand legal update: next step on the surrogacy bill (3 August 2026) — Secondary legal update dated 3 August 2026; reports proposal status, not enacted law.
- Royal Thai Government — public consultation on the revised surrogacy bill (19 July 2026)— Official announcement confirming the consultation window (2–31 July 2026) only; it does not establish the bill’s later legislative status.
- LawPlayer — Thai-language transcription of the 2015 ART Act (page data stated as of 11 October 2026) — Third-party Thai-language transcription; it warns later amendments may be missing and is not authoritative.








